Stay updated on Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1 while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:43:54.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The study record area displays a 403 Forbidden response with raw HTML markup and a Home link instead of study information.
    Difference
    0.5%
    Check dated 2026-10-05T17:41:15.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The 403 error content and the Home link were removed, exposing the standard study details view.
    Difference
    0.5%
    Check dated 2026-09-28T18:14:59.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A revision label was added, and a substantial list of metadata/keyword terms and related notes was removed from the page, reducing searchable terms and auxiliary information without altering the main study details.
    Difference
    17%
    Check dated 2026-09-21T22:07:49.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.5 to v3.6.6, reflecting a new version of the ClinicalTrials.gov content without changing the study details.
    Difference
    0.1%
    Check dated 2026-08-31T16:39:27.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.6.4 to v3.6.5, indicating a newer page build. No study content or user-facing functionality changes are indicated.
    Difference
    0.1%
    Check dated 2026-08-17T12:56:30.000Z thumbnail image

Stay in the know with updates to Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial page.